Innovating to improve health worldwide

We are the voice of the innovative pharmaceutical industry, collaborating for global health progress to improve lives everywhere.

Areas of work About us
A female lab technician examining the contents of a petri dish

Latest news

Expert insights 11 June 2026

The G7 cannot afford to lose its leadership in pharmaceutical innovation

Whilst G7 countries have long been the traditional home of pharmaceutical innovation, there is increased global competition, and there is a real risk that this longstanding leadership will be lost without concerted action. Ahead of the G7 Leaders’ Summit in Evian on 15-17 June 2026, David Reddy, Director General of IFPMA, stresses that sustaining innovation leadership must be a strategic priority in a rapidly evolving landscape.

Read more
Press release 11 June 2026

Pharmaceutical industry calls on G7 to invest in innovation to drive competitiveness, resilience, and growth

IFPMA and Leem call on G7 leaders to place pharmaceutical innovation at the centre of their economic and competitiveness agenda.

Read more
Statement 9 June 2026

UN Multi-Stakeholder Hearing on Pandemic Prevention, Preparedness, and Response (PPPR)

IFPMA statement at the UN Multi-Stakeholder Hearing on Pandemic Prevention, Preparedness, and Response (PPPR) in New York on 9 June. We share the same objective: a world better prepared to prevent, prepare for, detect, and respond to pandemics. Industry is a core part of that system, engaging in strengthening the health of populations, developing vaccines...

Read more
Statement 8 June 2026

Pharmaceutical industry’s response to the Ebola Bundibugyo virus disease outbreak

The latest Ebola Bundibugyo outbreak in Democratic Republic of Congo, Uganda, and neighbouring countries is deeply concerning. Pharmaceutical and biotech companies are working with global partners in a coordinated response. Accelerating the response As the scientific, humanitarian, and global health response accelerates to contain the outbreak, pharmaceutical companies remain central to these efforts. While no...

Read more
Expert insights 8 June 2026

Innovative medicines as drivers of economic security – A strategic imperative for G7 economies

In his latest op-ed for the flagship publication “G7 France: The Evian Summit 2026” by Global Governance Media, David Reddy, IFPMA Director General, argues that pharmaceutical innovation should be a economic priority for G7 countries.

Read more
Expert insights
The G7 cannot afford to lose its leadership in pharmaceutical innovation
Press release
Pharmaceutical industry calls on G7 to invest in innovation to drive competitiveness, resilience, and growth
Statement
UN Multi-Stakeholder Hearing on Pandemic Prevention, Preparedness, and Response (PPPR)
Statement
Pharmaceutical industry’s response to the Ebola Bundibugyo virus disease outbreak
Expert insights
Innovative medicines as drivers of economic security – A strategic imperative for G7 economies

Initiatives

See all

#AlwaysInnovating

Investing in innovative medicines and vaccines doesn’t just save lives – it transforms our future. It strengthens health, drives economic growth, and improves health security.

Read more

#VaccinesForLife

Investing in adult vaccination programmes can help protect lives, our healthcare systems, and our economies. Read the new report by the Office of Health Economics to discover more.

Read more

#AlwaysInnovating

#AlwaysInnovating lifts the curtain on the innovation journey, revealing the knowledge, skills, collaboration, and perseverance needed to turn an idea into a medicine or vaccine that brings hope to people everywhere.

Read more

Global Health Progress

Explore how the innovative pharmaceutical industry is collaborating across global health actors to support the Sustainable Development Goals in low- and middle-income countries.

Visit microsite
#VaccinesForLife skyscraper
#alwaysinnovating campaign image - an illustration of a microscope with a lightbulb
Global Health Progress campaign image - a group of children in front of the SDG wheel
A female lab technician looking through a microscope

Collaborating for global health progress

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents the innovative pharmaceutical industry at the international level and in official relations with the United Nations.

About us

Areas of work

See all
Lightbulb

Fostering a thriving health innovation ecosystem
Heart

Advancing sustainable health systems
Mask

Improving health security and pandemic preparedness
Document

Strengthening regulatory systems
Scales

Upholding ethics and business integrity
Africa

Supporting Africa’s health ecosystem  

Our members

Representing over 90 of the most forward-looking companies and associations in the world.

See all
Moderna logo
Gilead Sciences logo
CSL Seqirus logo
Chugai logo
Sanofi logo
Lilly logo
Grünenthal logo
Pfizer logo
Top